MRSN - Mersana Therapeutics, Inc.
29.08
0.040 0.138%
Share volume: 712,460
Last Updated: 01-05-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$29.04
0.04
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-09-2024 | 08-13-2024 | 11-13-2024 | 03-03-2025 | 05-15-2025 | 08-13-2025 | 11-14-2025 | |
| Cash flow financing | 5.829 M | 153.000 K | -23.000 K | -1.867 M | -3.137 M | -3.108 M | -17.761 M | |
| Other financing cash flows | -65.000 K | -47.000 K | -23.000 K | 44.000 K | -12.000 K | -12.000 K | -32.000 K | |
| Cash flow | -99.375 M | -16.188 M | 19.870 M | 28.882 M | -5.463 M | -25.315 M | -20.581 M | |
| Net income | -19.306 M | -24.268 M | -11.501 M | -14.117 M | -24.123 M | -24.296 M | -7.545 M | |
| Depreciation | 423.000 K | 403.000 K | 402.000 K | 400.000 K | 316.000 K | 287.000 K | 83.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -72.547 M | 5.514 M | 28.470 M | 50.000 M | 27.000 M | 395.000 K | 372.000 K | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 132.000 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | -372.000 K | |
| Cash Change | -99.375 M | -16.188 M | 19.870 M | 28.882 M | -5.463 M | -25.315 M | -20.581 M |